A randomized control trial: The role of an alkalinising agent (potassium citrate) in paediatric urinary tract infection (UTI)

Not Applicable

Recruiting

• Conditions: rinary Tract Infection; Urinary Tract Infection; Infection - Studies of infection and infectious agents

• Registration Number: ACTRN12623000129684
• Lead Sponsor: niversiti Sains Malaysia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-02-07
• Last Update Posted: 15 July 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

•Age 1 month to 18 years old at diagnosis
•All inpatients diagnosed with acute UTI or/and recurrent UTI during their first or subsequent visit to hospital

; •Age 1 month to 18 years old at diagnosis
•All inpatients diagnosed with acute UTI or/and recurrent UTI during their first or subsequent visit to hospital

Exclusion Criteria

•Patient who had been treated with antibiotics less than 72 hours before presentation
•Patient who is allergic to potassium citrate
•Patient with underlying chronic renal failure, untreated Addison disease as well as patient who is on potassium sparing agent
•Patient who previously already recruited in the study
; •Patient who had been treated with antibiotics less than 72 hours before presentation
•Patient who is allergic to potassium citrate
•Patient with underlying chronic renal failure, untreated Addison disease as well as patient who is on potassium sparing agent
•Patient who previously already recruited in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rine pH<br>- assessed using urinalysis<br><br>[ to assess the parameters on admission (pre-treatment) and 48 hours (post commencement of treatment)<br>];Time to achieve resolution of the symptoms<br>- assessed using patient medical records[ progress of patients are observed at 5, 6 and 7 days post-commencement of treatment];Duration of hospital stay<br>- assessed using patient medical records[ Progress of patients are observed at 5, 6 and 7 days post-commencement of treatment];Urine pH<br>- assessed using urinalysis<br><br>[ to assess the parameters on admission (pre-treatment) and 48 hours (post commencement of treatment)<br>];Time to achieve resolution of the symptoms<br>- assessed using patient medical records[ progress of patients are observed at 5, 6 and 7 days post-commencement of treatment];Duration of hospital stay<br>- assessed using patient medical records[ Progress of patients are observed at 5, 6 and 7 days post-commencement of treatment]